The technique of duplex scanning for the diagnosis of deep venous thrombosis (DVT) has been developed in 3 stages. Initially B-mode imaging with compression was used. Subsequently interrogation of the venous lumen using the Doppler facility was introduced and finally the latter became simple and efficient with the introduction of colour flow imaging. Sensitivities and specificities in excess of 90% have been produced for thrombosis proximal to the calf by all methods in symptomatic patients. Colour flow imaging has given the best results for calf DVT in symptomatic patients with 86% sensitivity and 91% specificity. Before the introduction of colour flow imaging the accuracy for the detection of old thrombi in asymptomatic patients was poor. With the introduction of colour, sensitivities and specificities in excess of 90% have been obtained for proximal DVT; for calf DVT, sensitivity of 79% and specificity of 97% have been reported by 2 studies. If further studies substantiate these recent results duplex scanning will become the non-invasive method to be used in screening asymptomatic patients.

Keywords:
Deep venous thrombosis, Duplex scanning, Post-operative surgery
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.